researchintokyo.com

Japan Market Access

Japan Market Access

  • Home
  • Japan Market Access
    • Coverage Decisions
    • Pricing and Reimbursement
  • Approvals
    • List of New Drugs/Indications Approved in Japan in 2014
  • Services
    • Marketing Authorization
  • Blog
  • About Us
  • Contact Us

Recent Posts

  • Protected:
  • Anti-VEGF Battles: Eylea Overtakes Lucentis in Japan
  • iPS Cell Regenerative Medicine to Rely on Donor Cells in Order to Cut 77% of Costs
  • Plan: Generics to increase from 60% to 80% by 2017
  • Average Nursing Care Premium Breaks Through ¥5000

Approvals

Drug Regulatory Affairs in Japan

Drug Regulatory Affairs in Japan

List of approved drugs in Japan in 2014

· © 2024 researchintokyo.com · Designed by Press Customizr · Powered by ·